SHALBY / NSE / Healthcare Facilities
Shalby
1Y Price Trend
Key Information
Recommendations
RatingBuy
Target High274.5
Target Low125.7
Target Mean2
Target Median25
Risk Metrics
Overall RiskBalanced risk
Board Risk41.85
Key Analysis
Overall score, performance score, return rating, defensive, aggressive, and balanced views.
Download appProjection Analytics
Best-case, base-case, worst-case, and dynamic AI projection views.
Download appLatest stock news
Here’s a quick look at stocks likely to be in focus in today's trade.
Stocks to buy or sell: Sumeet Bagadia has recommended buying these breakout stocks today — Shilpa Medicare, Marksans Pharma, Ahluwalia Contracts, Shalby, and BEPL
Here are some stocks to watch out for ahead of Thursday's trading session
Shares of Shalby, India’s leading multi-specialty hospital, have gained 124% in the last six months, moving from ₹ 139 to ₹ 311.15 per share. In today's trading session, the stock jumped 1.7% to hit a new record high of ₹ 323.60 apiece.
The market outlook for the near term is uncertain and experts recommend buying technically and fundamentally sound stocks at the current juncture.
Q2 Result Preview: Better occupancy rates, improving average revenues per operating bed (APROB) are the key reasons which keep analysts positive on better performance by hospitals during Q2. Apollo, Fortis, Medanta (Global Health), Shalby, rainbow are amongst analysts top picks
Day trading stocks: Market experts have recommended six stocks to buy today — HUL, DMart, Shalby, RBL Bank, Maruti Suzuki and Dr Lal Pathlabs
A total of seven stocks will trade ex-dividend today. The ex-dividend date is the day on which the price of an equity share adjusts to reflect the next dividend payout.
© SharekeyX | Rusaka Technologies 2024-2026

